Avipsa Ghosh is an experienced medicinal chemist currently serving as an Associate Principal Scientist at AstraZeneca since June 2018, where responsibilities include leading a Tier 1 project and overseeing the design and synthesis of small molecule inhibitors for oncology targets. Significant contributions include work on the development of the PARP1-selective inhibitors AZD5305 and AZD9574, both in Phase II clinical trials, and participation in the CDK2-selective inhibitor program leading to AZD8421, currently in Phase I clinical trial. Prior experience includes roles at the Massachusetts Institute of Technology as a Postdoctoral Associate and Iowa State University, where Ghosh earned a PhD in Organic Chemistry, along with teaching positions. Early career experience involved process chemistry at AstraZeneca India, focusing on scalable routes for active pharmaceutical ingredients. Educational qualifications include a Postdoctoral Associate degree from Massachusetts Institute of Technology, a PhD from Iowa State University, an MSc from Bangalore University, and a BSc from Maharaja Manindrachandra College.
July, 2023 - present
June, 2018
Deputy Director, Data Science And AI at Applied Materials
Director Data Science at Applied Materials
Data Science Solutions Lead at Elevance Health
Director, Digital Learning Labs And Data Science at Applied Materials
VP ML For Drug Discovery, Gred Computational Sciences, Genentech at Genentech
Access the worlds's biggest network of public org charts
Learn more